Newsletter | April 22, 2024

04.22.24 -- Benefits Of A Diverse Board

SPONSOR

DIA 2024

DIA 2024 invites industry, regulators, governments, academics, innovators, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in San Diego, DIA 2024 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.

FEATURED ARTICLE

Continuing Down The Road To BioPharma Board Diversification

Diversification in the boardroom improves the quality of board performance, encourages objectivity, and expands the quality of debate and decision making. Biopharmaceutical industry boardrooms are making progress, but still have work to do.

INDUSTRY INSIGHTS

Three Areas Of Impact To The Clinical Trial Patient Experience

Panelists examine the primary challenges encountered by patients and explore ongoing initiatives aimed at improving their overall experience. Learn about strategies designed to eliminate logistical barriers.

Opportunities In Pharmaceutical Outsourcing: Portfolio Maintenance

The emerging frontier in outsourcing involves managing established products, offering revenue sustainability, cost-efficiency, and compliance assurance.

Is Your Medical Information Website Better Than Dr. Google?

Pharmaceutical companies need dedicated medical affairs resources to communicate with HCPs and consumers to ensure the material they find is up-to-date and accurate.

Leveraging Bio-Functional Assays For Charged Variants Characterization

The heterogeneity of a biologic product has implications for the final therapy's safety and efficacy. Explore challenges associated with charged variants, including mAbs and fusion proteins.

Biopharma Resilience: Mass Immunization Programs

Review the challenges involved with mass immunization programs, what role government can play in facilitating vaccination programs, how technology is transforming the biopharma industry, and more.

Streamline Early-Stage Development To Reach The Clinic Faster

Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: